Clinical isolates of Fusobacterium nucleatum display strain-specific virulence and modulation by indole derivatives
This study reveals significant strain-specific heterogeneity in *Fusobacterium nucleatum* virulence and indole production among clinical isolates, demonstrating that indole derivatives can differentially inhibit biofilm formation and cancer cell invasion while offering a potential pathway for precision therapeutic targeting of pathogenic strains without harming beneficial commensals.